Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.480
-0.018 (-1.23%)
At close: Dec 31, 2025
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $3.95 million as of December 31, 2025. Its market cap has decreased by -62.68% in one year.
Market Cap
3.95M
Enterprise Value
22.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.48
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 3.95M, a decrease of -88.45%. That is a compound annual growth rate of -6.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.95M | -70.97% |
| Dec 31, 2024 | 13.59M | -32.53% |
| Dec 29, 2023 | 20.15M | -62.12% |
| Dec 30, 2022 | 53.19M | -56.27% |
| Dec 31, 2021 | 121.64M | -68.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 298.05M |
| Nika Pharmaceuticals | 291.10M |